Skip to main content
Have a personal or library account? Click to login
Genetic Polymorphism TNFα -308G>A and Ischemic Stroke in Northern Romania Cover

Genetic Polymorphism TNFα -308G>A and Ischemic Stroke in Northern Romania

Open Access
|Aug 2013

References

  1. 1. World Health Organization. Reducing risks, promoting healthy life. The World Health Report. 2002, Geneva
  2. 2. Ohman EM, Bhatt DL, Steg PG, et al. The Reduction of Atherothrombosis for Continued Health (REACH) Registry: an international, prospective, observational investigation in subjects at risk for atherothrombotic eventsstudy design. Am Heart J 2006; 151:786-796
  3. 3. Cinteza M, Pana B, Cochino M, et al. Prevalence and control of cardiovascular risk factors in Romania cardio-zone national study. Mædica A Journal of Clinical Medicine. 2007;2(4).
  4. 4. Kiely DK, Wolf PA, Cupples LA, Beiser AS, Myers RH. Familial aggregation of stroke. The Framingham Study. Stroke. 1993;24:1366-1371.
  5. 5. Liao D, Myers R, Hunt S, Shahar E, Paton C, et al. Familial history of stroke and stroke risk. The Family Heart Study. Stroke. 1997;28:1908-1912.
  6. 6. Alberts MJ. Genetic aspects of cerebrovascular disease. Stroke. 1991;22(2):276-80.
  7. 7. Ariyaratnam R, Casas JP, Whittaker J, et al. Genetics of ischaemic stroke among persons of non-European descent: a meta-analysis of eight genes involving approximately 32,500 individuals. PLoS Med. 2007;4(4):e131.
  8. 8. Matarin M, Brown WM, Dena H, et al. Candidate gene polymorphisms for ischemic stroke, Stroke. 2009;40(11):3436-42. Epub 2009 Sep 3.
  9. 9. Carr FJ, McBride MW, Carswell HVO, et al. Genetic Aspects of Stroke: Human and Experimental Studies. Journal of Cerebral Blood Flow & Metabolism. 2002;22:767-773.
  10. 10. Cvetkovic JT, Wiklund PG, Ahmed E, et al. Polymorphisms of IL-1b, IL-1Ra, and TNF-α genes: A nested case-control study of their association with risk for stroke. Journal of Stroke & Cerebrovascular Diseases. 2005;14(1):29-35.
  11. 11. Clark WM. Cytokines and reperfusion injury. Neurology. 1997;Suppl.4:10-4
  12. 12. Revilla M, Castillo J, Davalos A, Chamorro A. A-174G/C polymorphism of the interleukin 6 gene in patients with lacular infarction. Neurosci Lett. 2002;324:29-32.
  13. 13. Hoppe C, Klitz W, D’Harlingue K, et al. Confirmation of an association between the TNF(−308) promoter polymorphism and stroke risk in children with sickle cell anemia. Stroke. 2007;38:2241-2246.
  14. 14. Um JY, Lee JH, Joo JC, et al. Association between tumor necrosis factoralpha gene polymorphism and Sasang constitution in cerebral infarction. Am J Chin Med. 2005;33:547-557.
  15. 15. Hallenbeck JM. Cytokines, macrophages and leukocytes in brain ischemia. Neurology. 1997;24:445-451.
  16. 16. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539-1558.
  17. 17. Welton NJ, Caldwell DM, Adamopoulos E, Vedhara K. Mixed treatment comparison meta-analysis of complex interventions: psychological interventions in coronary heart disease. Am J Epidemiol. 2009;169:1158-1165.
  18. 18. Guanglin Cui et al. Polymorphism of tumor necrosis factor alpha (TNFalpha) gene promoter, circulating TNF-alpha level, and cardiovascular risk factor for ischemic stroke. Journal of Neuroinflammation. 2012;9:235
  19. 19. Ishii T, Matsuse T, Teramoto S, et al. Neither IL-1beta, IL-1 receptor antagonist, nor TNF-alpha polymorphisms are associated with susceptibility to COPD. Respir Med. 2000;94(9):847-51.
  20. 20. Zhang LF, Yang J, Hong Z, et al. Collaborative Group of China Multicenter Study of Cardiovascular Epidemiology. Proportion of different subtypes of stroke in China. Stroke. 2003;34:2091-2096.
  21. 21. Dichgans M, Markus HS. Genetic association studies in stroke: methodological issues and proposed standard criteria. Stroke. 2005;36: 2027-203.
  22. 22. Liu T, Clark RK, McDonnell PC, et al. Tumor necrosis factor-alpha expression in ischemic neurons. Stroke. 1994;25:1481-1488
  23. 23. Achrol AS, Pawlikowska L, McCulloch CE, et al. Tumor necrosis factor-α -238G > A promoter polymorphism is associated with increased risk of new hemorrhage in the natural course of patients with brain arteriovenous malformations. Stroke. 2006;37:231-234.
  24. 24. Bis JC, Heckbert SR, Smith NL, et al. Variation in inflammation-related genes and risk of incident nonfatal myocardial infarction or ischemic stroke. Atherosclerosis. 2008;198:166-173.
  25. 25. Banerjee I, Gupta V, Ahmed T, et al. Inflammatory system gene polymorphism and the risk of stroke: a case-control study in an Indian population. Brain Res Bull. 2008;75:158-165.
  26. 26. Tong Y, Geng Y, Xu J, et al. The role of functional polymorphisms of the TNF-alpha gene promoter in the risk of ischemic stroke in Chinese Han and Uyghur populations: two case-control studies. Clin. Chim. Acta. 2010;411:1291-1295.
  27. 27. Hoppe C, Klitz W, D’Harlingue K, et al. Confirmation of an association between the TNF(-308) promoter polymorphism and stroke risk in children with sickle cell anemia. Stroke. 2007;38:2241-2246.
  28. 28. Khan SA, Aslam M, Owais M, Zaheer MS. Correlation between tumour necrosis factor-alpha and other co-variates and different grades of blood pressure in essential hypertensive patients. Ind medica Biomedical Research. 2010;21(2):184-188.
  29. 29. Zhao Y, Xia S, Zou L. The association between polymorphism of TNF-alpha gene and hypertensive disorder complicating pregnancy. J Huazhong Univ Sci Technolog Med Sci. 2007;27(6):729-32.
  30. 30. Yan-yan Li. Tumor Necrosis Factor-Alpha G308α Gene Polymorphism and Essential Hypertension: A Meta-Analysis Involving 2244 Participants. PLoS ONE. 2012;7(4):e35408.
DOI: https://doi.org/10.2478/amma-2013-0016 | Journal eISSN: 2668-7763 (formerly 2247-6113) | Journal ISSN: 2668-7755
Language: English
Page range: 75 - 77
Published on: Aug 13, 2013
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2013 Felicia Petrișor, Ra Popp, Andreea Cătană, M Porojan, Iv Pop, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons License.